First Time Loading...

Intercept Pharmaceuticals Inc
NASDAQ:ICPT

Watchlist Manager
Intercept Pharmaceuticals Inc Logo
Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Watchlist
Price: 19 USD Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

ICPT Price Targets Summary
Intercept Pharmaceuticals Inc

Wall Street analysts forecast ICPT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ICPT is 19 USD .

Lowest
Price Target
Not Available
Average
Price Target
19 USD
0% Upside
Highest
Price Target
Not Available

ICPT Last Price Targets
Intercept Pharmaceuticals Inc

The latest public price target was made on Jul 13, 2023 by Ed Arce from H.C. Wainwright , who expects ICPT stock to drop by 0% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ed Arce
H.C. Wainwright
19 USD
Downside 0%
9 months ago
Jul 13, 2023
H.C. Wainwright Double Upgrades Intercept Pharmaceuticals (ICPT) to Buy
StreetInsider
Edward Nash
Canaccord Genuity
19 USD
Downside 0%
9 months ago
Jun 29, 2023
Canaccord Genuity Upgrades Intercept Pharmaceuticals (ICPT) to Buy
StreetInsider
Ed Arce
H.C. Wainwright
Price Target 19 USD
Upside/Downside 0%
View Source
Edward Nash
Canaccord Genuity
Price Target 19 USD
Upside/Downside 0%
View Source
Intercept Pharmaceuticals Inc Competitors:
Price Targets
HPHA
Heidelberg Pharma AG
288% Upside
YS
YS Biopharma Co Ltd
451% Upside
2157
Lepu Biopharma Co Ltd
25% Downside
TLX
Telix Pharmaceuticals Ltd
2% Upside
TNGX
Tango Therapeutics Inc
141% Upside
CNTA
Centessa Pharmaceuticals PLC
56% Upside
AGIO
Agios Pharmaceuticals Inc
39% Upside
DSGN
Design Therapeutics Inc
28% Upside

Revenue
Forecast

Revenue Estimate
Intercept Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Intercept Pharmaceuticals Inc's revenue is 90%. The projected CAGR for the next 3 years is 9%.

90%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Intercept Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Intercept Pharmaceuticals Inc

The compound annual growth rate of Intercept Pharmaceuticals Inc's net income for the next 3 years is -31%.

N/A
Past Growth
-31%
Estimated Growth
Estimates Accuracy
-30%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ICPT's stock price target?
Price Target
19 USD

According to Wall Street analysts, the average 1-year price target for ICPT is 19 USD .

What is Intercept Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Intercept Pharmaceuticals Inc's revenue is 90%. The projected CAGR for the next 3 years is 9%.

What is Intercept Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
-31%

The compound annual growth rate of Intercept Pharmaceuticals Inc's net income for the next 3 years is -31%.